27.18
+0.08
+(0.30%)
As of 2:09:09 PM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 71,583 | 4 |
Sales | 682,373 | 3 |
Net Shares Purchased (Sold) | -610,790 | 7 |
Total Insider Shares Held | 99.45k | -- |
% Net Shares Purchased (Sold) | -86.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale at price 26.10 per share. | Indirect | 16,983,714 | Jan 24, 2025 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 25.60 - 25.90 per share. | Indirect | 3,862 | Jan 8, 2025 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 25.90 per share. | Direct | 7,770 | Dec 31, 2024 |
HUGHES OWEN Chief Executive Officer | Sale at price 29.95 per share. | Direct | 655,336 | Nov 13, 2024 |
BURNS THOMAS M Chief Financial Officer | Sale at price 29.94 per share. | Direct | 292,664 | Nov 13, 2024 |
HUGHES OWEN Chief Executive Officer | -- | Direct | -- | Nov 11, 2024 |
BURNS THOMAS M Chief Financial Officer | -- | Direct | -- | Nov 11, 2024 |
WYSZOMIERSKI JACK L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2024 |
PERRY MATTHEW D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2024 |
HERNDAY NATASHA A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2024 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 13.89 - 14.25 per share. | Direct | 24,848 | Oct 3, 2023 |
HUGHES OWEN Chief Executive Officer | Purchase at price 13.83 per share. | Direct | 13,830 | Oct 2, 2023 |
HUGHES OWEN Chief Executive Officer | Purchase at price 14.43 - 14.65 per share. | Direct | 36,075 | Sep 26, 2023 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 17.00 - 17.20 per share. | Indirect | 25,700 | May 31, 2023 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 19.00 per share. | Direct | 16,150 | May 23, 2023 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 19.50 per share. | Direct | 19,500 | May 19, 2023 |
SITKO BRADLEY J. Chief Investment Officer | Purchase at price 18.66 - 19.00 per share. | Indirect | 37,985 | May 12, 2023 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
23.24
-0.15%
WPDPF WPD Pharmaceuticals Inc.
0.0000
0.00%
HSTOQ Histogen Inc.
0.0287
0.00%
PHGUF Pharming Group N.V.
0.8690
0.00%
ISCO International Stem Cell Corporation
0.1050
+16.67%
MIRM Mirum Pharmaceuticals, Inc.
50.62
-0.20%
ELDN Eledon Pharmaceuticals, Inc.
4.4600
-0.89%
ALZ.ST Alzinova AB (publ)
3.0400
+1.33%
J90.F NurExone Biologic Inc.
0.4440
+11.56%
CDTX Cidara Therapeutics, Inc.
24.92
+6.20%